> top > docs > PubMed:23755867 > annotations

PubMed:23755867 JSONTXT

Annnotations TAB JSON ListView MergeView

Allie

Id Subject Object Predicate Lexical cue
SS1_23755867_2_0 336-346 expanded denotes heart rate
SS2_23755867_2_0 348-350 abbr denotes HR
SS1_23755867_4_0 499-514 expanded denotes pharmacokinetic
SS2_23755867_4_0 516-518 abbr denotes PK
SS1_23755867_4_1 524-539 expanded denotes pharmacodynamic
SS2_23755867_4_1 541-543 abbr denotes PD
AE1_23755867_2_0 SS1_23755867_2_0 SS2_23755867_2_0 abbreviatedTo heart rate,HR
AE1_23755867_4_0 SS1_23755867_4_0 SS2_23755867_4_0 abbreviatedTo pharmacokinetic,PK
AE1_23755867_4_1 SS1_23755867_4_1 SS2_23755867_4_1 abbreviatedTo pharmacodynamic,PD

PubmedHPO

Id Subject Object Predicate Lexical cue
T1 423-436 HP_0001635 denotes heart failure

Zierdiyeerkenaili_800_3

Id Subject Object Predicate Lexical cue
T1 180-190 CI denotes ivabradine
T10 2795-2805 CI denotes ivabradine
T11 238-248 CI denotes Ivabradine
T12 2577-2587 CI denotes Ivabradine
T2 865-875 CI denotes ivabradine
T3 942-952 CI denotes ivabradine
T4 1142-1152 CI denotes ivabradine
T5 1650-1660 CI denotes ivabradine
T6 2065-2075 CI denotes ivabradine
T7 2296-2306 CI denotes ivabradine
T8 2393-2403 CI denotes ivabradine
T9 2495-2505 CI denotes ivabradine
T13 893-900 CI denotes placebo
T14 725-732 CI denotes placebo
T15 2097-2104 CI denotes placebo
T16 2318-2325 CI denotes placebo

yaoziqian_800_3

Id Subject Object Predicate Lexical cue
T1 180-190 CI denotes ivabradine
T10 2296-2306 CI denotes ivabradine
T11 2393-2403 CI denotes ivabradine
T12 2577-2587 CI denotes Ivabradine
T13 2795-2805 CI denotes ivabradine
T2 238-248 CI denotes Ivabradine
T3 865-875 CI denotes ivabradine
T6 1142-1152 CI denotes ivabradine
T7 1650-1660 CI denotes ivabradine
T8 2065-2075 CI denotes ivabradine
T9 2097-2104 CI denotes placebo
T14 893-900 CI denotes placebo
T15 725-732 CI denotes placebo
T16 2318-2325 CI denotes placebo
T17 942-952 CI denotes ivabradine
T18 2495-2505 CI denotes ivabradine